Biomerics

Biomerics positions itself as an engineering partner that handles design-for-manufacturability reviews, material selection, and automation integration alongside physical production. Its website emphasizes proactive engineering of creative customer solutions, suggesting it gets involved well before the transfer-to-manufacturing stage for complex interventional components.

The Costa Rica campuses represent a nearshore manufacturing hub that allows OEM customers to shift production out of Asia without moving all the way to the United States. Biomerics claims it is the largest and longest-operating CDMO in the country, which implies deep regulatory registrations, a trained workforce, and institutional knowledge of operating in a free-trade-zone environment serving U.S. and European medtech firms.

The firm manufactures plastic components ranging from large enclosures to micro-scale parts, micro metal fabrications for robotic and device subsystems, and performs final device assembly. Its 'pellets to finished devices' description indicates it takes raw polymer feedstock and delivers packaged units, capturing the full bill of materials for many catheter-based and robotic interventional products.

There is no publicly available information confirming government contracts or direct public-sector relationships. The firm's communications are exclusively oriented toward commercial OEM customers developing interventional products.

Traditional medtech contract manufacturers often specialize in a single process — injection molding, machining, or cleanroom assembly — and OEMs must orchestrate multiple vendors. Biomerics consolidates polymer processing, micro metals fabrication, and automation engineering under one roof with a single quality system, which reduces the integration risk and project-management overhead that fragmented supply chains create.